Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Role of bacterial virulence factors and host factors in the outcome of Escherichia coli bacteraemia.

Hekker TA, Groeneveld AB, Simoons-Smit AM, de Man P, Connell H, MacLaren DM.

Eur J Clin Microbiol Infect Dis. 2000 Apr;19(4):312-6.

PMID:
10834824
2.

Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis.

Morré SA, Ossewaarde JM, Lan J, van Doornum GJ, Walboomers JM, MacLaren DM, Meijer CJ, van den Brule AJ.

J Clin Microbiol. 1998 Feb;36(2):345-51.

4.

Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents.

Debets-Ossenkopp YJ, Namavar F, MacLaren DM.

Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):353-5.

PMID:
7649202
5.

Diversity in lipid A binding ligands: comparison of lipid A monoclonal antibodies with rBPI23.

Appelmelk BJ, Qing AY, Helmerhorst EJ, Maaskant JJ, Abraham PR, Thijs LG, MacLaren DM.

Prog Clin Biol Res. 1995;392:453-63.

PMID:
8524952
6.

Comparative in-vitro activity of piperacillin-tazobactam against recent clinical isolates, a Dutch national multicentre study.

Stobberingh EE, Maclaren DM, Schmitz PI.

J Antimicrob Chemother. 1994 Nov;34(5):777-83.

PMID:
7706173
7.

[Successful culture of Chlamydia pneumoniae in 2 asymptomatic patients].

Tjhie HT, Kock JH, Theunissen JJ, Stolz E, MacLaren DM.

Ned Tijdschr Geneeskd. 1994 Sep 17;138(38):1913-6. Dutch.

PMID:
7935937
8.

The sensitivity of clinical isolates of anaerobic species to piperacillin-tazobactam and other antimicrobial agents.

Namavar F, Severin WP, Stobberingh E, Smeets T, MacLaren DM.

J Antimicrob Chemother. 1994 Sep;34(3):415-9. No abstract available.

PMID:
7829416
9.

Utilization of haem from the haptoglobin-haemoglobin complex by Bacteroides fragilis.

Otto BR, Sparrius M, Wors DJ, de Graaf FK, MacLaren DM.

Microb Pathog. 1994 Sep;17(3):137-47.

PMID:
7700131
10.

Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand.

Appelmelk BJ, An YQ, Thijs BG, MacLaren DM, de Graaff J.

Infect Immun. 1994 Aug;62(8):3564-7.

11.

A multicenter survey of resistance in The Netherlands using the Etest.

van Klingeren B, Stobberingh EE, MacLaren DM, Schmitz PI, Murmans M, Smeets T, Dessens M.

Diagn Microbiol Infect Dis. 1994 Jul;19(3):151-6.

PMID:
7820994
12.

Lactoferrin is a lipid A-binding protein.

Appelmelk BJ, An YQ, Geerts M, Thijs BG, de Boer HA, MacLaren DM, de Graaff J, Nuijens JH.

Infect Immun. 1994 Jun;62(6):2628-32.

13.

The role of neuraminidase in haemagglutination and adherence to colon WiDr cells by Bacteroides fragilis.

Namavar F, Van der Bijl MW, Appelmelk BJ, De Graaff J, MacLaren DM.

J Med Microbiol. 1994 Jun;40(6):393-6.

PMID:
8006931
14.

Frequencies of lipopolysaccharide core types in Escherichia coli strains from bacteraemic patients.

Appelmelk BJ, An YQ, Hekker TA, Thijs LG, MacLaren DM, de Graaf J.

Microbiology. 1994 May;140 ( Pt 5):1119-24.

PMID:
7517766
15.

Binding studies of a monoclonal antibody specific for 3-deoxy-D-manno-octulosonic acid with a panel of Klebsiella pneumoniae lipopolysaccharides representing all of the O serotypes.

van der Meer NM, Appelmelk BJ, Verweij-van Vught AM, Nimmich W, Kosma P, Thijs LG, de Graaff J, MacLaren DM.

Infect Immun. 1994 Mar;62(3):1052-7.

17.

Direct PCR enables detection of Mycoplasma pneumoniae in patients with respiratory tract infections.

Tjhie JH, van Kuppeveld FJ, Roosendaal R, Melchers WJ, Gordijn R, MacLaren DM, Walboomers JM, Meijer CJ, van den Brule AJ.

J Clin Microbiol. 1994 Jan;32(1):11-6.

18.

Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.

Appelmelk BJ, Maaskant JJ, Verweij-van Vught AM, van der Meer NM, Thijs BG, MacLaren DM.

J Gen Microbiol. 1993 Nov;139(11):2641-7.

PMID:
7506295
19.

Antimicrobial prophylaxis in surgery: microbiological factors.

MacLaren DM.

J Antimicrob Chemother. 1993 Sep;32(3):507. No abstract available.

PMID:
8262875
20.

Migration of rat peritoneal cells after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.

Verweij WR, Namavar F, Schouten WF, de Graaff J, MacLaren DM.

J Gen Microbiol. 1993 Aug;139(8):1739-44.

PMID:
8409916
21.

[The return of serious infections caused by Streptococcus pyogenes].

Maclaren DM.

Ned Tijdschr Geneeskd. 1993 Jun 26;137(26):1318-9. Dutch. No abstract available.

PMID:
8345889
22.

Reappraisal of endotoxin in gram-negative sepsis?

Appelmelk BJ, de Graaff J, Thijs LG, MacLaren DM.

Lancet. 1993 Jun 26;341(8861):1662. No abstract available.

PMID:
8100023
23.

Direct detection and genotyping of Chlamydia trachomatis in cervical scrapes by using polymerase chain reaction and restriction fragment length polymorphism analysis.

Lan J, Walboomers JM, Roosendaal R, van Doornum GJ, MacLaren DM, Meijer CJ, van den Brule AJ.

J Clin Microbiol. 1993 May;31(5):1060-5.

24.

Helicobacter pylori and pathogenesis of ulceration.

Namavar F, MacLaren DM.

Lancet. 1993 Mar 13;341(8846):702-3. No abstract available.

PMID:
8095617
25.

Enhancement of complement-mediated killing of Neisseria gonorrhoeae by antibodies to lipopolysaccharide of Escherichia coli J5.

Appelmelk BJ, Verweij-van Vught M, Maaskant JJ, Thijs BG, Maclaren DM.

J Infect Dis. 1993 Mar;167(3):773-5. No abstract available.

PMID:
8499020
26.

Polymyxin B-horseradish peroxidase conjugates as tools in endotoxin research.

Appelmelk BJ, Su D, Verweij-van Vught AM, Thijs BG, MacLaren DM.

Anal Biochem. 1992 Dec;207(2):311-6.

PMID:
1481986
27.

Blood substitutes and infection.

Otto BR, Verweij-van Vught AM, MacLaren DM.

Nature. 1992 Jul 2;358(6381):23-4. No abstract available.

PMID:
1614525
28.

Characterization and detection of the 40 kDa fimbrial subunit of Bacteroides fragilis BE1.

van Doorn J, Oudega B, MacLaren DM.

Microb Pathog. 1992 Jul;13(1):75-9.

PMID:
1359379
29.

Murine ascitic fluids contain varying amounts of an inhibitor that interferes with complement-mediated effector functions of monoclonal antibodies.

Appelmelk BJ, Verweij-Van Vught AM, Maaskant JJ, Thijs LG, MacLaren DM.

Immunol Lett. 1992 Jul;33(2):135-8.

PMID:
1280247
30.

Retrospective study to determine the diagnostic value of the Widal test in a non-endemic country.

Koeleman JG, Regensburg DF, van Katwijk F, MacLaren DM.

Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):167-70.

PMID:
1396731
31.

Transferrins and heme-compounds as iron sources for pathogenic bacteria.

Otto BR, Verweij-van Vught AM, MacLaren DM.

Crit Rev Microbiol. 1992;18(3):217-33. Review.

PMID:
1532495
32.

Human immune response to an iron-repressible outer membrane protein of Bacteroides fragilis.

Otto BR, Verweij WR, Sparrius M, Verweij-van Vught AM, Nord CE, MacLaren DM.

Infect Immun. 1991 Sep;59(9):2999-3003.

33.

Early events after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.

Verweij WR, Namavar F, Schouten WF, MacLaren DM.

J Med Microbiol. 1991 Jul;35(1):18-22.

PMID:
2072375
34.

[Smoke about leg cramps].

Maclaren DM.

Ned Tijdschr Geneeskd. 1991 Jun 22;135(25):1146. Dutch. No abstract available.

PMID:
1857445
35.

A study of the candidate virulence factors of Bacteroides fragilis.

Namavar F, Verweij-Van Vught MA, Maclaren DM.

J Gen Microbiol. 1991 Jun;137(6):1431-5.

PMID:
1919517
36.

Iron-regulated outer membrane protein of Bacteroides fragilis involved in heme uptake.

Otto BR, Sparrius M, Verweij-van Vught AM, MacLaren DM.

Infect Immun. 1990 Dec;58(12):3954-8.

37.

Piperacillin/tazobactam and ticarcillin/clavulanic acid against resistant Enterobacteriaceae.

Kempers J, MacLaren DM.

J Antimicrob Chemother. 1990 Oct;26(4):598-9. No abstract available.

PMID:
2174855
38.

[The treatment of dog and cat bites].

Koeleman JG, Roggeveen C, MacLaren DM.

Ned Tijdschr Geneeskd. 1990 Aug 25;134(34):1665-6. Dutch. No abstract available.

PMID:
2215712
39.

Cryptococcal meningo-encephalitis after prolonged corticosteroid therapy.

Koeleman JG, Rustemeijer C, Wijermans PW, MacLaren DM.

Neth J Med. 1990 Jun;36(5-6):242-5.

PMID:
2203976
40.

Timing of booster doses of hepatitis B vaccine.

Nommensen FE, MacLaren DM, Go ST.

Lancet. 1990 Feb 24;335(8687):479-80. No abstract available.

PMID:
1968203
41.

Purification and partial characterization of an iron regulated outer membrane protein of B. fragilis under non-denaturing conditions.

Otto BR, Verweij-Van Vught AM, Maclaren DM.

FEMS Microbiol Lett. 1990 Jan 1;54(1-3):285-90.

PMID:
2323541
42.

Half-life of HBs antibody after hepatitis B vaccination: an aid to timing of booster vaccination.

Nommensen FE, Go ST, MacLaren DM.

Lancet. 1989 Oct 7;2(8667):847-9.

PMID:
2571769
43.

Epidemiology of the Bacteroides fragilis group in the colonic flora in 10 patients with colonic cancer.

Namavar F, Theunissen EB, Verweij-Van Vught AM, Peerbooms PG, Bal M, Hoitsma HF, MacLaren DM.

J Med Microbiol. 1989 Jul;29(3):171-6.

PMID:
2746627
44.

Screening for asymptomatic bacteriuria in the elderly.

MacLaren DM.

Lancet. 1989 Jun 17;1(8651):1393-4. No abstract available.

PMID:
2567411
45.

Comparison of monoclonal antibodies to the deeper core region of gram-negative lipopolysaccharide by means of polymyxin B inhibition studies.

Appelmelk BJ, Verweij-van Vught AM, Maaskant JJ, Schouten WF, Thijs LG, MacLaren DM.

Microb Pathog. 1988 Oct;5(4):297-301.

PMID:
2853278
46.

Prevention of lethal endotoxemia in actinomycin D-sensitized mice by incubation of Salmonella minnesota R595 lipopolysaccharide with monoclonal antibodies to R595.

Appelmelk BJ, Verweij-van Vught AM, Brade H, Maaskant JJ, Schouten WF, Thijs LG, MacLaren DM.

Microb Pathog. 1988 Oct;5(4):251-7.

PMID:
2467166
47.

Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.

Appelmelk BJ, Verweij-van Vught AM, Maaskant JJ, Schouten WF, De Jonge AJ, Thijs LG, Maclaren DM.

J Med Microbiol. 1988 Jun;26(2):107-14.

PMID:
2455054
48.

Outer membrane proteins of Bacteroides fragilis and Bacteroides vulgatus in relation to iron uptake and virulence.

Otto BR, Verweij-van Vught AM, van Doorn J, Maclaren DM.

Microb Pathog. 1988 Apr;4(4):279-87.

PMID:
3200164
49.

Treatment of respiratory tract infections with pefloxacin in critically ill patients hospitalized in a surgical intensive care unit.

Boland DM, van Gestel WC, MacLaren DM, de Jong D.

Pharm Weekbl Sci. 1987 Dec 11;9 Suppl:S58-9.

PMID:
3325930
50.

Comparative activities of five antimicrobial agents in experimental Proteus pyelonephritis in mice.

Peerbooms PG, Maclaren DM.

Pharm Weekbl Sci. 1987 Dec 11;9 Suppl:S30-2.

PMID:
3325927

Supplemental Content

Loading ...
Support Center